![](/images/award_icon.png)
Antisense inhib of vascular endothelial growth factorsAward last edited on: 2/25/02
Sponsored Program
SBIRAwarding Agency
NIH : NCITotal Award Amount
$50,000Award Phase
1Solicitation Topic Code
-----Principal Investigator
Gregory S RobisonCompany Information
Aceragen Inc (AKA: Idera Pharmaceuticals Inc~Hybridon Inc)
Location: Multiple
Congr. District: 04
County: Durham
Congr. District: 04
County: Durham
Phase I
Contract Number: 1R43CA061435-01Start Date: 00/00/00 Completed: 00/00/00
Phase I year
1993Phase I Amount
$50,000Thesaurus Terms:
Plasmodium, antimalarial agent, antisense nucleic acid, drug design /synthesis /production, drug screening /evaluation, oligonucleotide Plasmodium berghei, Plasmodium falciparum, dihydrofolate reductase, pharmacokinetics chicken, laboratory mouse, nucleic acid chemical synthesis
Phase II
Contract Number: ----------Start Date: 00/00/00 Completed: 00/00/00